Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06505057

Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients (HKCH)

Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
Female
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Ovarian tissue freezing is an ideal option for these patients as it can be performed immediately and does not need any time for ovarian stimulation. We hope we can develop this service in our locality to allow more young female cancer patients to have their fertility preserved.

Detailed description

To date, transplantation of cryopreserved ovarian tissue has resulted in births of at least 130 children but data on transplantation of ovarian tissue removed before puberty are scarce. During ovarian tissue cryopreservation (OTC), it is possible to freeze isolated oocytes. In 2003, Revel et al described for the first time oocyte isolation in children younger than 12 years with seven, eight and seven oocytes isolated from the ovarian cortex of patients aged 5, 8 and 10 years, respectively. At this moment, financial constraint is another great hindrance to fertility preservation in Hong Kong as the procedure is not cheap. Cryopreservation of gametes and embryos involving assisted reproductive technology is expensive and the costs of fertility preservation impose a great burden to these cancer patients on top of the great expenses for their chemo- or radiotherapy. It is almost impossible for underprivileged families. Young cancer patients may often need immediate gonadotoxic treatment for their cancer, just like those with haematological cancers. In these patients, egg or embryo freezing is not possible as it takes at least 8-12 days' time for ovarian stimulation. Ovarian tissue freezing is an ideal option for these patients as it can be performed immediately and does not need any time for ovarian stimulation. We hope we can develop this service in our locality to allow more young female cancer patients to have their fertility preserved.

Conditions

Interventions

TypeNameDescription
OTHEROvarian Tissue Cryopreservation and Subsequent Auto-TransplantationOvarian Tissue Cryopreservation and Subsequent Auto-Transplantation

Timeline

Start date
2024-08-13
Primary completion
2039-07-31
Completion
2041-07-31
First posted
2024-07-17
Last updated
2026-01-08

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT06505057. Inclusion in this directory is not an endorsement.